Today: 7 March 2026
Subscribe
Browse Category

Stock Market 10 February 2026

Vale stock price slips premarket after courts reject 2.846 bln-real asset-freeze bids

Vale stock price slips premarket after courts reject 2.846 bln-real asset-freeze bids

Vale’s U.S.-listed shares fell 0.8% to $16.66 premarket after Brazilian courts rejected most asset-freeze requests tied to January overflows at its sites. One 200 million reais freeze request remains pending, while operations at Fábrica and Viga units stay suspended. Investors await Vale’s quarterly results due Feb. 12. Iron ore futures in Singapore edged up 0.5% to $100.4 a ton.
10 February 2026
·
Kenvue stock price today: KVUE holds near $18 as Feb. 17 results and Kimberly-Clark deal hang over the week

Kenvue stock price today: KVUE holds near $18 as Feb. 17 results and Kimberly-Clark deal hang over the week

Kenvue shares traded flat in premarket Tuesday, holding at $18.18 after Monday’s close. The company will report fourth-quarter and full-year results on Feb. 17 with no earnings call, citing its pending merger with Kimberly-Clark. Shareholders of record Feb. 11 will receive a $0.2075 dividend. The merger, approved Jan. 29, is expected to close in the second half of 2026, pending regulatory review.
10 February 2026
··
Snap stock jumps in premarket after analyst upgrade as SNAP tries to rebound

Snap stock jumps in premarket after analyst upgrade as SNAP tries to rebound

Snap Inc. shares rose 3.7% to $5.38 in premarket trading after Arete Research upgraded the stock to buy and trimmed its price target to $7.30. The move follows a volatile stretch after Snap’s quarterly results and a new $500 million buyback plan. Snap ended Monday at $5.19, near the bottom of its 52-week range. Analyst sentiment remains cautious, with most ratings at “Hold.”
10 February 2026
··
Plug Power stock (PLUG) steadies before the bell as make-or-break share vote nears

Plug Power stock (PLUG) steadies before the bell as make-or-break share vote nears

Plug Power shares held at $2.10 in premarket trading Tuesday as investors awaited a Feb. 17 shareholder vote on expanding authorized shares to 3 billion. The company failed to secure enough votes last week, with only 39.63% backing Proposal 1. CEO Andy Marsh warned a reverse stock split could follow if the measure fails. Plug shares remain down 54% from their 52-week high.
10 February 2026
··
Hims & Hers stock drops again premarket as $49 weight-loss pill reversal fuels legal, FDA scrutiny

Hims & Hers stock drops again premarket as $49 weight-loss pill reversal fuels legal, FDA scrutiny

Hims & Hers Health shares dropped 4.2% to $18.52 premarket Tuesday after plunging 16% Monday. The company halted its compounded semaglutide pill following warnings from U.S. regulators and a new patent lawsuit by Novo Nordisk. The FDA signaled plans to restrict non-approved GLP-1 drugs and may take legal action. The Department of Health and Human Services referred Hims to the Justice Department.
10 February 2026
···
Jumia stock drops premarket as Q4 revenue trails estimates; 2026 outlook, Algeria exit in focus

Jumia stock drops premarket as Q4 revenue trails estimates; 2026 outlook, Algeria exit in focus

Jumia shares dropped 3.75% to $11.81 in premarket trading after fourth-quarter revenue rose 34% to $61.4 million, missing estimates. The company forecast 2026 GMV growth of up to 32% and an adjusted EBITDA loss of $25–$30 million, and said it will exit Algeria in the first quarter. Operating loss narrowed to $10.6 million. Liquidity stood at $77.8 million at year-end.
10 February 2026
···
Fiserv stock rises in premarket after earnings beat, but 2026 “transition year” looms

Fiserv stock rises in premarket after earnings beat, but 2026 “transition year” looms

Fiserv shares rose about 3% in premarket trading Tuesday after fourth-quarter adjusted earnings per share fell 21% to $1.99 but beat analyst estimates. The company forecast 2026 adjusted EPS of $8.00 to $8.30 and organic revenue growth of 1% to 3%. Shares last closed at $60.11, down 74% over the past year. Investors await more detail on growth plans at the 8 a.m. ET earnings call.
10 February 2026
··
Datadog stock swings in focus after Q4 beat, mixed 2026 outlook puts DDOG back on traders’ screens

Datadog stock swings in focus after Q4 beat, mixed 2026 outlook puts DDOG back on traders’ screens

Datadog reported fourth-quarter revenue up 29% to $953 million, beating estimates, but issued a first-quarter profit outlook below expectations. Shares rose in premarket trading. The company forecast first-quarter revenue of $951 million to $961 million and full-year revenue up to $4.10 billion. Investors await further detail on 2026 demand and margins at today’s call and Thursday’s investor day.
10 February 2026
··
Upwork stock sinks about 26% in premarket after soft outlook jars investors (UPWK)

Upwork stock sinks about 26% in premarket after soft outlook jars investors (UPWK)

Upwork shares fell about 26% in premarket trading Tuesday to $13.92 after forecasting first-quarter revenue and profit below Wall Street estimates. The company beat fourth-quarter expectations but warned of a softer start to 2026. Active clients dropped to 785,000 at year-end. Upwork cited spending on enterprise and marketing as reasons for lower margin guidance.
10 February 2026
··
TUI stock drops as summer bookings slip, muting record Q1 profit boost

TUI stock drops as summer bookings slip, muting record Q1 profit boost

TUI shares fell 3.5% to 9.02 euros in Frankfurt after the company reported slightly weaker booked revenue for summer 2026, despite its best first-quarter underlying EBIT since 2014. Booked revenue was down 2% for summer and 1% for winter 2025/26. TUI reaffirmed its full-year guidance and reported net debt improved to 3.6 billion euros. Investors focused on late-booking trends and profit delivery for the peak season.
10 February 2026
·
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health shares rose 3.3% to $12.66 in premarket trading after forecasting 2026 revenue of $18.7–$19.0 billion and operating earnings of $250–$450 million. The company posted a wider Q4 net loss of $353 million and a medical loss ratio of 95.4%. A U.S. House panel subpoenaed Oscar and other insurers over ACA subsidy practices. Oscar also disclosed a new $475 million revolving credit facility.
10 February 2026
·
US economic calendar today: Retail sales, import prices and a $58 billion Treasury auction set the tone for stocks

US economic calendar today: Retail sales, import prices and a $58 billion Treasury auction set the tone for stocks

U.S. stock index futures were flat early Tuesday ahead of December retail sales and trade price data due at 8:30 a.m. ET. The Dow, S&P 500, and Nasdaq all closed higher Monday, with the Dow hitting a second straight record. The NFIB small-business optimism index slipped to 99.3 in January. The Treasury will auction $58 billion in 3-year notes at 1 p.m. ET.
10 February 2026
·
Cisco’s new AI networking chip puts Nvidia and Broadcom back in the AI stocks spotlight

Cisco’s new AI networking chip puts Nvidia and Broadcom back in the AI stocks spotlight

Cisco unveiled its Silicon One G300 networking chip for AI data centers Tuesday, targeting a market dominated by Nvidia and Broadcom. Cisco shares closed at a 52-week high Monday, up 2.3% to $86.78. The chip, built on TSMC’s 3-nanometer process, is set for release in the second half of 2026. Investors await Cisco’s earnings report on Feb. 11 for signs of AI demand.
10 February 2026
····
1 … 104 105 106 107 108 … 1,338
Go toTop